InsiderClue
Insiders · Profile

LONGENECKER JOHN P PHD

Director at Pacira BioSciences · President and CEO at Rein Therapeutics. Filing since 28 Mar 2013. CIK 0001288231

PCRX Pacira BioSciences, Inc. Director · 13 trades RNTX Rein Therapeutics, Inc. President and CEO · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
PCRX Pacira BioSciences, Inc.
3 Mar 2022
Director
Sold, plan not stated
7,000
$502.15K
27.1%
PCRX Pacira BioSciences, Inc.
1 Mar 2021
Director
Sold, plan not stated
5,000
$361.30K
22.0%
PCRX Pacira BioSciences, Inc.
2 Dec 2019
Director
Sold, plan not stated
1,300
$59.97K
9.2%
RNTX Rein Therapeutics, Inc.
10 Aug 2018
President and CEO
Bought
10,000
$24.50K
opened
PCRX Pacira BioSciences, Inc.
12 Jan 2016
Director
Bought
300
$19.96K
15.0%
PCRX Pacira BioSciences, Inc.
12 Mar 2015
Director
Sold, plan not stated
3,000
$285.84K
100%
PCRX Pacira BioSciences, Inc.
29 Dec 2014
Director
Sold, plan not stated
1,000
$93.32K
100%
PCRX Pacira BioSciences, Inc.
29 Sep 2014
Director
Sold, plan not stated
1,000
$96.40K
100%
PCRX Pacira BioSciences, Inc.
30 Jun 2014
Director
Sold, plan not stated
1,000
$91.60K
100%
PCRX Pacira BioSciences, Inc.
28 Mar 2014
Director
Sold, plan not stated
1,000
$64.63K
100%
PCRX Pacira BioSciences, Inc.
30 Dec 2013
Director
Sold, plan not stated
2,500
$138.88K
100%
PCRX Pacira BioSciences, Inc.
30 Sep 2013
Director
Sold, plan not stated
2,500
$116.85K
100%
PCRX Pacira BioSciences, Inc.
28 Jun 2013
Director
Sold, plan not stated
2,000
$56.18K
100%
PCRX Pacira BioSciences, Inc.
28 Mar 2013
Director
Sold, plan not stated
2,000
$56.98K
100%
14 decisions on file.